Treatment OutcomeHeart DiseasesAmlodipineMyocytes, CardiacMyocardial InfarctionPostoperative ComplicationsFollow-Up StudiesTime FactorsAtenololTroponin IRisk FactorsProspective StudiesCardiac OutputPrognosisPerindoprilAntihypertensive AgentsRisk AssessmentOutcome Assessment (Health Care)Predictive Value of TestsHeptanoic AcidsRetrospective StudiesMyocardial IschemiaHeartChest PainHypertensionHeart FailureMultivariate AnalysisVascular Surgical ProceduresCardiac Surgical ProceduresElectrocardiographyArrhythmias, CardiacCoronary DiseaseCardiovascular DiseasesPyrrolesDeath, Sudden, CardiacBiological MarkersPregnancy OutcomeHydroxymethylglutaryl-CoA Reductase InhibitorsBlood PressureIncidenceCoronary Artery DiseaseCardiac Pacing, ArtificialCardiac TamponadeCardiomegalyHeart ArrestCardiac CatheterizationMyocardiumMyocardial ContractionHeart VentriclesOutcome and Process Assessment (Health Care)CardiomyopathiesMyoblasts, CardiacEchocardiographyCardiac Imaging TechniquesOut-of-Hospital Cardiac ArrestCardiac MyosinsHeart RateCohort StudiesHemodynamicsCardiac Output, LowCardiac GlycosidesPregnancyHeart TransplantationSeverity of Illness IndexSurvival AnalysisInfant, NewbornSurvival RateVentricular Function, LeftHeart Defects, CongenitalVentricular RemodelingCardiac VolumeCardiopulmonary ResuscitationStroke VolumeKaplan-Meier EstimateCardiac Resynchronization TherapyVentricular Dysfunction, LeftTroponin THeart Function TestsCardiac Care FacilitiesCardiotonic AgentsHeart Conduction SystemLogistic ModelsDogsCardiomyopathy, DilatedAge FactorsDisease Models, AnimalHeart NeoplasmsUnited StatesRecurrenceReproducibility of ResultsRecovery of FunctionRandomized Controlled Trials as TopicRats, Sprague-DawleyFetal HeartCardiac ElectrophysiologyFibrosisModels, CardiovascularProportional Hazards ModelsChi-Square DistributionLength of Stay